Next-generation oral preexposure prophylaxis: beyond tenofovir - Wikidata - awgldk - TriplyDB

Next-generation oral preexposure prophylaxis: beyond tenofovir

Next-generation oral preexposure prophylaxis: beyond tenofovir

http://www.wikidata.org/entity/Q37067126

about

Antiretroviral pharmacology in mucosal tissues Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1.Human biotransformation of the nonnucleoside reverse transcriptase inhibitor rilpivirine and a cross-species metabolism comparison.A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective Pre- and post-sexual exposure prophylaxis of HIV: An update.Docking Field-based QSAR and pharmacophore studies on the substituted pyrimidine derivatives targeting HIV-1 reverse transcriptase.PrEP Implementation Science: State-of-the-Art and Research Agenda.HIV-1 Drug Resistance in Pre-exposure Prophylaxis Trials Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase

P2860

Q27014675-AB3F4333-3E41-433D-A2F7-A5D9BFCCCBAF Q30744184-A64C4C8B-4C31-4B3F-B410-C63AE5C6B6C7 Q33765789-27968407-AEEC-469E-AB7A-FFC513999755 Q35014689-5AFAD719-9D70-43DA-B73D-691891F14F95 Q35875723-795477DF-24C3-4B3A-BB4F-E50A6BA61C8B Q36933427-F6485851-86D9-4791-8669-2BE8C0D72265 Q37126494-1F889B9F-0F20-44AC-9B08-A5C5781F7068 Q37263885-8124FDAC-E54E-411C-AF6B-FA6C1E6DCE5D Q38672579-90FBCA32-D978-403F-A3B1-3F3AE3DE5BEB Q39262494-C2D22205-873B-4F4F-99C4-989BE2893F4C Q40080043-E2D65770-2229-43CF-8AC8-26A28ED3DA66 Q43241737-69F996C3-C86F-4DBD-A8C5-979E969433B1 Q57207278-1680A73E-7A52-4B19-96EC-7383B918840B Q58760446-D4992B18-2A99-4EBE-BB20-1EE28DB1D3A2

P2860

Next-generation oral preexposure prophylaxis: beyond tenofovir

http://www.wikidata.org/entity/Q37067126

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Next-generation oral preexposure prophylaxis: beyond tenofovir

@en

Next-generation oral preexposure prophylaxis: beyond tenofovir.

@nl

type

label

Next-generation oral preexposure prophylaxis: beyond tenofovir

@en

Next-generation oral preexposure prophylaxis: beyond tenofovir.

@nl

prefLabel

Next-generation oral preexposure prophylaxis: beyond tenofovir

@en

Next-generation oral preexposure prophylaxis: beyond tenofovir.

@nl

P1433

Q37067126-4470964F-B8DF-4B27-A585-79FC94D1CBAD

P1476

Q37067126-8E6EC75B-747F-4729-AF1F-F4E562EBCF80

P2093

Q37067126-5F5DA271-FD39-42D7-8CC5-90C6FDF5A1B0

Q37067126-C61839FB-4EAC-429F-A7FC-D8F0467C58F0

P2860

Q37067126-0E33A90E-BBFF-49BC-BF95-AAF0F35A5AD9

Q37067126-11FD84FE-CD3B-498D-887C-42A9CEA55C11

Q37067126-1A84D9A5-FAF2-45A8-B001-F5D9EE5D1719

Q37067126-1B44B712-C2FD-4678-802E-83621E8101C3

Q37067126-3C98D1BC-313E-4973-A5F8-56ECC5B83625

Q37067126-3D1D1F6D-7431-4B28-ACEB-7CEED303CF7F

Q37067126-4F41F8B9-E0AE-43AD-98F6-CE2765C24426

Q37067126-505F93D2-B6CE-49B7-B5C4-7332788BB393

Q37067126-6A0C04D5-DA85-41D9-86AA-A157D713C864

Q37067126-74AD9375-53C1-43BB-89E0-03BE8DD8223B

P304

Q37067126-A8E42C6F-2A3F-4730-B1AF-332FF5A4E30E

P31

Q37067126-CBF69938-1D8A-49C3-A940-3B5BD8A976FB

P356

Q37067126-846BFF1D-5AE3-4A21-912D-D08F59E94D9D

P433

Q37067126-0ABD2273-102C-4079-9582-B9E969E80EAF

P478

Q37067126-6D9E1ACC-FF85-4DF5-BB7F-A58E06D2DD06

P577

Q37067126-CFC8E161-CE99-4841-A5B0-08E786D1CEA8

P698

Q37067126-C6ED1097-A298-4E64-B410-08130B63B022

P932

Q37067126-E4065151-000A-49B1-812F-C7D663661D73

P356

COH.0B013E328358B9CE

P1433

Current Opinion in HIV and AIDS

P1476

Next-generation oral preexposure prophylaxis: beyond tenofovir

@en

P2093

Bisrat K Abraham

http://www.w3.org/2001/XMLSchema#string

Roy Gulick

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Raltegravir with optimized background therapy for resistant HIV-1 infection

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.

Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.

Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles.

Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

P304

600-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/COH.0B013E328358B9CE

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23032733

http://www.w3.org/2001/XMLSchema#string

P932

3732461

http://www.w3.org/2001/XMLSchema#string